$ESPR New reports that 3 major payers are board June 1 to cover bempedoic acid and many moving up their drug tier status non that the label is expanded for both primary& secondary prevention. The only non statin for primary prevention
#CardioTwitter
#Statinintolernce
#Diabetes
$ESPR
شركة ادوية اعلنت نتائجها قبل قليل متضمنه نمو جيد في الايرادات و الربحية
الشركة تعتبر فرصة بسعر تحت 2.50$
و تستحق سعر فوق 4$
#للاستثمار
#الاسهم_الامريكية
#السوق_الامريكي
wallstreetbets Congrats on the return of Roaring Kitty!
I’m still buying $ESPR
Life saving non statin heart therapy that comes without the nasty statin side effects. For some reason the sellers absolutely hate this stock but “I like the stock” and believe it going places. 📈📈📈